Table 3 Main clinical characteristics of included articles
No. | Year | First autor | Rhinoconjunctivitis severity (ARIA) | Asthma severity (GINA) | Mean age (SD or range) | PDCO groups of age | Patients not included in PP analysis | |
|---|---|---|---|---|---|---|---|---|
Active group (%) | Placebo group (%) | |||||||
1 | 2010 | Pfaar | Mild to severe | Only intermittent | 39 (18 to 65) | Only adults | 14.6 | 14.9 |
2 | 2013 | Pfaar | Moderate to severe | Only intermittent | 31 (12.4) | Adolescent included | 14.5 | 17.2 |
3 | 2012 | Pfaar | Moderate to severe | Only intermittent | 33 (11 to 69) | Children Included | 23.7 | 25 |
4 | 2010 | Höiby | Mild to severe | Intermittent to mild | 33 (7 to 69) | Children Included | 22.6 | 30 |
5 | 2006 | Colás | Mild to severe | Intermittent to mild | 34 (18 to 51) | Only adults | 5 | 5 |
6 | 2005 | Ameal | Mild to severe | Intermittent to moderate | 23 (14 to 48) | Adolescent included | 9.4 | 16.1 |
7 | 2006 | García-Robaina | Moderate to severe | Intermittent to moderate | 24 (9.3) | Adolescent included | 20 | 20 |
8 | 2005 | Álvarez-Cuesta | Moderate to severe | Intermittent to mild | 28 (17 to 58) | Adolescent included | – | – |